Multiplex Biomarker Imaging Market

Multiplex Biomarker Imaging Market: North America Expected to be the Most Attractive Regional Market During the Forecast Period: Global Industry Analysis 2012 - 2016 and Opportunity Assessment 2017 - 2027

Ask The Analyst Customization Available Request Methodology

The global multiplex biomarker imaging market is estimated to be valued at US$ 270 Mn in the year 2017 and is estimated to touch a value of US$ 843 Mn in the year 2027, exhibiting a CAGR of 12% during the period of assessment (2017-2027).

Increased spending on cancer diagnostic and monitoring

Growing incidence of cancer is resulting in increased spending by governments in various countries globally. Complications arising due to late diagnosis of cancer, especially with regard to blood and lung cancer, are resulting in need for more expensive treatments and medical procedures. The commercial success of multiplex biomarker imaging in research activities is driving demand for these systems in cancer research sector and is also expected to attract investment opportunities on clinical diagnostics applications in the near future. In order to curb the cancer wave, government in some countries are spending substantially on cancer diagnostic services and campaigns. According to National Health Society (NHS), U.K., cancer services incur a cost of around US$ 8.3 Bn to NHS, of which, majority of this amount is spent on diagnosis and monitoring. This shows the potential for multiplex biomarker imaging industry in cancer diagnostic and monitoring in future.

Increase in demand for multiplexing in multispectral imaging

Demand for multispectral imaging is increasing within multiplex biomarker imaging as it optimizes the opportunities for multiplexing while at the same time overcoming the effects of auto-fluorescence. These could serve multiple purposes such as detection of exact tumour location, expression of appropriate targetable surface markers, oxy-deoxy haemoglobin status, presence of necrosis or apoptosis and documentation of drug delivery. An increase in production base of multispectral imaging devices that could provide multiplexing is expected to fuel the revenue growth of device manufacturers.

Unclear regulatory guidance on the commercial sale of digital pathology imaging products

There is no clear regulatory guidance on commercial diagnostic use of whole slide imaging (WSI) products including multiplex biomarker imaging systems. As such regulatory bodies have indicated that there is no definitive period within which such guidelines could be formulated. In the U.S., multiplex biomarker imaging devices have found main usage in cancer research in translation laboratories and academic institutes. This hampers profit generation of the multiplex biomarker imaging system manufacturers as they are not able to target commercial clinical diagnostic laboratories.

Instruments largely used for research purpose only

Currently, multiplex biomarker imaging products are approved for research use only. Both across Europe and North America, multiplex biomarker imaging products are directly sold by companies; along with software and multiple year service agreements to laboratories, biopharmaceutical companies and academic institutes. This makes pricing restrictive as reimbursement rates in these regions have gone down largely. In absence of documented benefits, these systems are yet to be utilized fully.

multiplex biomarker imaging market

Global Multiplex Biomarker Imaging Market Attractiveness Analysis by Region, 2017-2027

North America is estimated to dominate the global multiplex biomarker imaging market by region in terms of revenue in 2017, and the trend is projected to grow throughout the forecast period. North America market is the most attractive segment, with attractiveness index of 4.3 over the forecast period. Western Europe is expected to be second most attractive region in the global multiplex biomarker imaging market by region, with attractiveness index of 1.8 during the forecast period. MEA and Latin America are the least attractive segment for global multiplex biomarker imaging market, with attractiveness index of 0.1 over the forecast period.

Introduction

Future Market Insights presents yet another comprehensive and an insightful report titled ‘Multiplex Biomarker Imaging Market: Global Industry Analysis 2012 – 2016 and Opportunity Assessment 2017 – 2027’. In this report, multiplex biomarker imaging is defined as a unique technique for imaging the characteristics and analysis of exact disease. Biomarkers are in the form of biological markers used in clinical studies to picture the current state of the disease.

Report Structure

This report is divided into four distinct parts to offer clarity and easy readability to the report audiences. The first section of the report is the introduction, which contains the executive summary of the report, the market taxonomy and the definition of the product, namely, multiplex biomarker imaging, by product type and the market viewpoint. The global multiplex biomarker imaging market opportunity analysis is also given in the introduction section. In another subsection of the introduction part, the rules and regulations applying to the multiplex biomarker imaging market from different regions of the world are given. The pricing analysis of the multiplex biomarker imaging market is also given in the introduction section. The second part of the report contains the regional multiplex biomarker imaging market analysis and the regions are chosen as per the market taxonomy. This section contains a valuable subsection which explains the market dynamics of each region of the multiplex biomarker imaging market. These market dynamics are in the form of drivers and restrains and give information about the factors that are responsible for the growth of the multiplex biomarker imaging market and the factors that are responsible for restraining the multiplex biomarker imaging market. The last part of the report contains the global multiplex biomarker imaging market analysis and forecast by region, by component type, by imaging technique, by application and by end user. This section of the report contains important market numbers in the form of market attractiveness index, incremental dollar opportunity and basis point share analysis.

Competition Landscape

Another part of this report contains the competition landscape that contains information about the key players operating in the global multiplex biomarker imaging market. The competition landscape contains a dashboard view of the companies and also have the detailed information for each of the leading individual companies operating in the global multiplex biomarker imaging market. This information is in the form of company description, product overview, key developments, strategic overview and key financials of each of the individual companies. In addition, a SWOT analysis of each of the companies profiled is also given which gives the report audiences information about the strengths, weaknesses, opportunities and the threats that the leading companies operating in the global multiplex biomarker imaging market are facing. This competition landscape is a valuable part of the report as it contains all the necessary information to study the leading companies operating in the global multiplex biomarker imaging market in detail and find how they implement their strategies and vision to stay at top in this highly competitive market. This type of information is invaluable for the new entrants in the global multiplex biomarker imaging market as they can learn quite a bit from the leading companies operating in this market. Also, the information provided in the competition landscape is also valuable for the established companies in the global multiplex biomarker imaging market as they come to know about their competitors and the strategies they have adopted to stay at the pole position in this cut- throat market.

Research Methodology

Overall market size has been analysed through historical data, primary responses, and public domain data. Revenue of companies in the multiplex biomarker imaging market has been benchmarked to ascertain the market size for the base year. Macroeconomic indicators such as GDP and industry growth have been considered to forecast the market size over the forecast period. The historical growth trend of end-use industries, market participants’ performance, as well as the present macro-economic outlook has been taken into consideration for estimating the overall market trend forecast. This data is then validated using the triangulation method and is extensively scrutinised using advanced tools to garner quantitative and qualitative insights into the global multiplex biomarker imaging market.  

Market Taxonomy

Component Type

Imaging Technique

Application

End-User

Region

  • Instruments

  • Quantitative Pathology

  • Imaging System

  • Immunofluorescence Slide Scanner

  • Toponome imaging System

  • Multispectral Imaging

  • Systems

  • Software

  • Services

  • Installation & Integration

  • Services

  • Maintenance Service

  • Immunohistochemistry (IHC) Assay

  • Fluorescent In Situ

  • Hybridization (FISH) Assay

  • Tissue Microarray (TMA) Assay

  • Research

  • Clinical Diagnostics

  • Translation Laboratories

  • Biopharmaceutical Companies

  • Academic Institutes

  • North America

  • Latin America

  • Western Europe

  • Eastern Europe

  • Asia Pacific Excluding

  • Japan (APEJ)

  • Japan

  • Middle East and Africa

Multiplex Biomarker Imaging Market Reports - Table of Contents

1. Executive Summary

1.1. Market Overview

1.2. Market Analysis

1.3. FMI Analysis and Recommendations

1.4. Wheel of Fortune

2. Market Introduction

2.1. Market Taxonomy

2.2. Market Definition

3. Market View Point

3.1. Macro-Economic Factors

3.2. Opportunity Analysis

3.3. Regulatory Scenario

4. North America Multiplex Biomarker Imaging Market Analysis 2012–2016 and Forecast 2017–2027

4.1. Introduction

4.2. Regional Market Dynamics

4.2.1. Drivers

4.2.2. Restraints

4.2.3. Trends

4.3. Historical Market Size (US$ Mn) Analysis By Country, 2012-2016

4.3.1. U.S.

4.3.2. Canada

4.4. Market Size (US$ Mn) Forecast By Country, 2017-2027

4.4.1. U.S.

4.4.2. Canada

4.5. Historical Market Size (US$ Mn) and Volume Analysis By Component Type, 2012-2016

4.5.1. Instruments

4.5.1.1. Quantitative Pathology Imaging System

4.5.1.2. Immunofluorescence Slide Scanner

4.5.1.3. Multispectral Imaging Systems

4.5.1.4. Toponome imaging System

4.5.2. Software

4.5.3. Services

4.5.3.1. Installation & Integration Services

4.5.3.2. Maintenance Service

4.6. Market Size (US$ Mn) and Volume Forecast By Component Type, 2017-2027

4.6.1. Instruments

4.6.1.1. Quantitative Pathology Imaging System

4.6.1.2. Immunofluorescence Slide Scanner

4.6.1.3. Multispectral Imaging Systems

4.6.1.4. Toponome imaging System

4.6.2. Software

4.6.3. Services

4.6.3.1. Installation & Integration Services

4.6.3.2. Maintenance Service

4.7. Historical Market Size (US$ Mn) Analysis by Imaging Technique, 2012-2016

4.7.1. Immunohistochemistry (IHC) Assay

4.7.2. Fluorescent In Situ Hybridization (FISH) Assay

4.7.3. Tissue Microarray (TMA) Assay

4.8. Market Size (US$ Mn) Forecast, by Imaging Technique, 2017-2027

4.8.1. Immunohistochemistry (IHC) Assay

4.8.2. Fluorescent In Situ Hybridization (FISH) Assay

4.8.3. Tissue Microarray (TMA) Assay

4.9. Historical Market Size (US$ Mn) Analysis by Application, 2012-2016

4.9.1. Research

4.9.2. Clinical Diagnostics

4.10.Market Size (US$ Mn) Forecast, by Application, 2017-2027

4.10.1. Research

4.10.2. Clinical Diagnostics

4.11.Historical Market Size (US$ Mn) Analysis by Application, 2012-2016

4.11.1. Translational Laboratories

4.11.2. Biopharmaceutical Companies

4.11.3. Academic Institutes

4.12.Market Size (US$ Mn) Forecast, by Application, 2017-2027

4.12.1. Translational Laboratories

4.12.2. Biopharmaceutical Companies

4.12.3. Academic Institutes

4.13.Drivers and Restraints: Impact Analysis

4.14. Market Attractiveness Analysis

4.14.1. By Country

4.14.2. By Component Type

4.14.3. By Imaging Technique

4.14.4. Application

4.14.5. End User

4.15. Key Representative Market Presence (Intensity Map)

5. Latin America Multiplex Biomarker Imaging Market Analysis 2012–2016 and Forecast 2017–2027

5.1. Introduction

5.2. Regional Market Dynamics

5.2.1. Drivers

5.2.2. Restraints

5.2.3. Trends

5.3. Historical Market Size (US$ Mn) Analysis By Country, 2012-2016

5.3.1. Brazil

5.3.2. Mexico

5.3.3. Argentina

5.3.4. Rest of Latin America

5.4. Market Size (US$ Mn) Forecast By Country, 2017-2027

5.4.1. Brazil

5.4.2. Mexico

5.4.3. Argentina

5.4.4. Rest of Latin America

5.5. Historical Market Size (US$ Mn) and Volume Analysis By Component Type, 2012-2016

5.5.1. Instruments

5.5.1.1. Quantitative Pathology Imaging System

5.5.1.2. Immunofluorescence Slide Scanner

5.5.1.3. Multispectral Imaging Systems

5.5.1.4. Toponome imaging System

5.5.2. Software

5.5.3. Services

5.5.3.1. Installation & Integration Services

5.5.3.2. Maintenance Service

5.6. Market Size (US$ Mn) and Volume Forecast By Component Type, 2017-2027

5.6.1. Instruments

5.6.1.1. Quantitative Pathology Imaging System

5.6.1.2. Immunofluorescence Slide Scanner

5.6.1.3. Multispectral Imaging Systems

5.6.1.4. Toponome imaging System

5.6.2. Software

5.6.3. Services

5.6.3.1. Installation & Integration Services

5.6.3.2. Maintenance Service

5.7. Historical Market Size (US$ Mn) Analysis by Imaging Technique, 2012-2016

5.7.1. Immunohistochemistry (IHC) Assay

5.7.2. Fluorescent In Situ Hybridization (FISH) Assay

5.7.3. Tissue Microarray (TMA) Assay

5.8. Market Size (US$ Mn) Forecast, by Imaging Technique, 2017-2027

5.8.1. Immunohistochemistry (IHC) Assay

5.8.2. Fluorescent In Situ Hybridization (FISH) Assay

5.8.3. Tissue Microarray (TMA) Assay

5.9. Historical Market Size (US$ Mn) Analysis by Application, 2012-2016

5.9.1. Research

5.9.2. Clinical Diagnostics

5.10.Market Size (US$ Mn) Forecast, by Application, 2017-2027

5.10.1. Research

5.10.2. Clinical Diagnostics

5.11.Historical Market Size (US$ Mn) Analysis by Application, 2012-2016

5.11.1. Translational Laboratories

5.11.2. Biopharmaceutical Companies

5.11.3. Academic Institutes

5.12.Market Size (US$ Mn) Forecast, by Application, 2017-2027

5.12.1. Translational Laboratories

5.12.2. Biopharmaceutical Companies

5.12.3. Academic Institutes

5.13.Drivers and Restraints: Impact Analysis

5.14. Market Attractiveness Analysis

5.14.1. By Country

5.14.2. By Component Type

5.14.3. By Imaging Technique

5.14.4. Application

5.14.5. End User

5.15. Key Representative Market Presence (Intensity Map)

6. Western Europe Multiplex Biomarker Imaging Market Analysis 2012–2016 and Forecast 2017–2027

6.1. Introduction

6.2. Regional Market Dynamics

6.2.1. Drivers

6.2.2. Restraints

6.2.3. Trends

6.3. Historical Market Size (US$ Mn) Analysis By Country, 2012-2016

6.3.1. U.K.

6.3.2. Germany

6.3.3. France

6.3.4. Italy

6.3.5. Spain

6.3.6. Nordics

6.3.7. BENELUX

6.3.8. Rest of Western Europe

6.4. Market Size (US$ Mn) Forecast By Country, 2017-2027

6.4.1. U.K.

6.4.2. Germany

6.4.3. France

6.4.4. Italy

6.4.5. Spain

6.4.6. Nordics

6.4.7. BENELUX

6.4.8. Rest of Western Europe

6.5. Historical Market Size (US$ Mn) and Volume Analysis By Component Type, 2012-2016

6.5.1. Instruments

6.5.1.1. Quantitative Pathology Imaging System

6.5.1.2. Immunofluorescence Slide Scanner

6.5.1.3. Multispectral Imaging Systems

6.5.1.4. Toponome imaging System

6.5.2. Software

6.5.3. Services

6.5.3.1. Installation & Integration Services

6.5.3.2. Maintenance Service

6.6. Market Size (US$ Mn) and Volume Forecast By Component Type, 2017-2027

6.6.1. Instruments

6.6.1.1. Quantitative Pathology Imaging System

6.6.1.2. Immunofluorescence Slide Scanner

6.6.1.3. Multispectral Imaging Systems

6.6.1.4. Toponome imaging System

6.6.2. Software

6.6.3. Services

6.6.3.1. Installation & Integration Services

6.6.3.2. Maintenance Service

6.7. Historical Market Size (US$ Mn) Analysis by Imaging Technique, 2012-2016

6.7.1. Immunohistochemistry (IHC) Assay

6.7.2. Fluorescent In Situ Hybridization (FISH) Assay

6.7.3. Tissue Microarray (TMA) Assay

6.8. Market Size (US$ Mn) Forecast, by Imaging Technique, 2017-2027

6.8.1. Immunohistochemistry (IHC) Assay

6.8.2. Fluorescent In Situ Hybridization (FISH) Assay

6.8.3. Tissue Microarray (TMA) Assay

6.9. Historical Market Size (US$ Mn) Analysis by Application, 2012-2016

6.9.1. Research

6.9.2. Clinical Diagnostics

6.10.Market Size (US$ Mn) Forecast, by Application, 2017-2027

6.10.1. Research

6.10.2. Clinical Diagnostics

6.11.Historical Market Size (US$ Mn) Analysis by Application, 2012-2016

6.11.1. Translational Laboratories

6.11.2. Biopharmaceutical Companies

6.11.3. Academic Institutes

6.12.Market Size (US$ Mn) Forecast, by Application, 2017-2027

6.12.1. Translational Laboratories

6.12.2. Biopharmaceutical Companies

6.12.3. Academic Institutes

6.13.Drivers and Restraints: Impact Analysis

6.14. Market Attractiveness Analysis

6.14.1. By Country

6.14.2. By Component Type

6.14.3. By Imaging Technique

6.14.4. Application

6.14.5. End User

6.15. Key Representative Market Presence (Intensity Map)

7. Eastern Europe Multiplex Biomarker Imaging Market Analysis 2012–2016 and Forecast 2017–2027

7.1. Introduction

7.2. Historical Market Size (US$ Mn) Analysis By Country, 2012-2016

7.2.1. Russia

7.2.2. Poland

7.2.3. Rest of Eastern Europe

7.3. Market Size (US$ Mn) Forecast By Country,2017-2027

7.3.1. Russia

7.3.2. Poland

7.3.3. Rest of Eastern Europe

7.4. Historical Market Size (US$ Mn) and Volume Analysis By Component Type, 2012-2016

7.4.1. Instruments

7.4.1.1. Quantitative Pathology Imaging System

7.4.1.2. Immunofluorescence Slide Scanner

7.4.1.3. Multispectral Imaging Systems

7.4.1.4. Toponome imaging System

7.4.2. Software

7.4.3. Services

7.4.3.1. Installation & Integration Services

7.4.3.2. Maintenance Service

7.5. Market Size (US$ Mn) and Volume Forecast By Component Type, 2017-2027

7.5.1. Instruments

7.5.1.1. Quantitative Pathology Imaging System

7.5.1.2. Immunofluorescence Slide Scanner

7.5.1.3. Multispectral Imaging Systems

7.5.1.4. Toponome imaging System

7.5.2. Software

7.5.3. Services

7.5.3.1. Installation & Integration Services

7.5.3.2. Maintenance Service

7.6. Historical Market Size (US$ Mn) Analysis by Imaging Technique, 2012-2016

7.6.1. Immunohistochemistry (IHC) Assay

7.6.2. Fluorescent In Situ Hybridization (FISH) Assay

7.6.3. Tissue Microarray (TMA) Assay

7.7. Market Size (US$ Mn) Forecast, by Imaging Technique, 2017-2027

7.7.1. Immunohistochemistry (IHC) Assay

7.7.2. Fluorescent In Situ Hybridization (FISH) Assay

7.7.3. Tissue Microarray (TMA) Assay

7.8. Historical Market Size (US$ Mn) Analysis by Application, 2012-2016

7.8.1. Research

7.8.2. Clinical Diagnostics

7.9. Market Size (US$ Mn) Forecast, by Application, 2017-2027

7.9.1. Research

7.9.2. Clinical Diagnostics

7.10.Historical Market Size (US$ Mn) Analysis by Application, 2012-2016

7.10.1. Translational Laboratories

7.10.2. Biopharmaceutical Companies

7.10.3. Academic Institutes

7.11.Market Size (US$ Mn) Forecast, by Application, 2017-2027

7.11.1. Translational Laboratories

7.11.2. Biopharmaceutical Companies

7.11.3. Academic Institutes

7.12. Market Attractiveness Analysis

7.12.1. By Country

7.12.2. By Component Type

7.12.3. By Imaging Technique

7.12.4. Application

7.12.5. End User

7.13. Key Representative Market Presence (Intensity Map)

8. Asia-Pacific Excluding Japan (APEJ) Multiplex Biomarker Imaging Market Analysis 2012–2016 and Forecast 2017–2027

8.1. Introduction

8.2. Regional Market Dynamics

8.2.1. Drivers

8.2.2. Restraints

8.2.3. Trends

8.3. Historical Market Size (US$ Mn) Analysis By Country, 2012-2016

8.3.1. China

8.3.2. India

8.3.3. Australia and New Zealand

8.3.4. ASEAN

8.3.5. Rest of APEJ

8.4. Market Size (US$ Mn) Forecast By Country, 2017-2027

8.4.1. China

8.4.2. India

8.4.3. Australia and New Zealand

8.4.4. ASEAN

8.4.5. Rest of APEJ

8.5. Historical Market Size (US$ Mn) and Volume Analysis By Component Type, 2012-2016

8.5.1. Instruments

8.5.1.1. Quantitative Pathology Imaging System

8.5.1.2. Immunofluorescence Slide Scanner

8.5.1.3. Multispectral Imaging Systems

8.5.1.4. Toponome imaging System

8.5.2. Software

8.5.3. Services

8.5.3.1. Installation & Integration Services

8.5.3.2. Maintenance Service

8.6. Market Size (US$ Mn) and Volume Forecast By Component Type, 2017-2027

8.6.1. Instruments

8.6.1.1. Quantitative Pathology Imaging System

8.6.1.2. Immunofluorescence Slide Scanner

8.6.1.3. Multispectral Imaging Systems

8.6.1.4. Toponome imaging System

8.6.2. Software

8.6.3. Services

8.6.3.1. Installation & Integration Services

8.6.3.2. Maintenance Service

8.7. Historical Market Size (US$ Mn) Analysis by Imaging Technique, 2012-2016

8.7.1. Immunohistochemistry (IHC) Assay

8.7.2. Fluorescent In Situ Hybridization (FISH) Assay

8.7.3. Tissue Microarray (TMA) Assay

8.8. Market Size (US$ Mn) Forecast, by Imaging Technique, 2017-2027

8.8.1. Immunohistochemistry (IHC) Assay

8.8.2. Fluorescent In Situ Hybridization (FISH) Assay

8.8.3. Tissue Microarray (TMA) Assay

8.9. Historical Market Size (US$ Mn) Analysis by Application, 2012-2016

8.9.1. Research

8.9.2. Clinical Diagnostics

8.10.Market Size (US$ Mn) Forecast, by Application, 2017-2027

8.10.1. Research

8.10.2. Clinical Diagnostics

8.11.Historical Market Size (US$ Mn) Analysis by Application, 2012-2016

8.11.1. Translational Laboratories

8.11.2. Biopharmaceutical Companies

8.11.3. Academic Institutes

8.12.Market Size (US$ Mn) Forecast, by Application, 2017-2027

8.12.1. Translational Laboratories

8.12.2. Biopharmaceutical Companies

8.12.3. Academic Institutes

8.13.Drivers and Restraints: Impact Analysis

8.14. Market Attractiveness Analysis

8.14.1. By Country

8.14.2. By Component Type

8.14.3. By Imaging Technique

8.14.4. Application

8.14.5. End User

8.15. Key Representative Market Presence (Intensity Map)

9. Japan Multiplex Biomarker Imaging Market Analysis 2012–2016 and Forecast 2017–2027

9.1. Introduction

9.2. Historical Market Size (US$ Mn) and Volume Analysis By Component Type, 2012-2016

9.2.1. Instruments

9.2.1.1. Quantitative Pathology Imaging System

9.2.1.2. Immunofluorescence Slide Scanner

9.2.1.3. Multispectral Imaging Systems

9.2.1.4. Toponome imaging System

9.2.2. Software

9.2.3. Services

9.2.3.1. Installation & Integration Services

9.2.3.2. Maintenance Service

9.3. Market Size (US$ Mn) and Volume Forecast By Component Type, 2017-2027

9.3.1. Instruments

9.3.1.1. Quantitative Pathology Imaging System

9.3.1.2. Immunofluorescence Slide Scanner

9.3.1.3. Multispectral Imaging Systems

9.3.1.4. Toponome imaging System

9.3.2. Software

9.3.3. Services

9.3.3.1. Installation & Integration Services

9.3.3.2. Maintenance Service

9.4. Historical Market Size (US$ Mn) Analysis by Imaging Technique, 2012-2016

9.4.1. Immunohistochemistry (IHC) Assay

9.4.2. Fluorescent In Situ Hybridization (FISH) Assay

9.4.3. Tissue Microarray (TMA) Assay

9.5. Market Size (US$ Mn) Forecast, by Imaging Technique, 2017-2027

9.5.1. Immunohistochemistry (IHC) Assay

9.5.2. Fluorescent In Situ Hybridization (FISH) Assay

9.5.3. Tissue Microarray (TMA) Assay

9.6. Historical Market Size (US$ Mn) Analysis by Application, 2012-2016

9.6.1. Research

9.6.2. Clinical Diagnostics

9.7. Market Size (US$ Mn) Forecast, by Application, 2017-2027

9.7.1. Research

9.7.2. Clinical Diagnostics

9.8. Historical Market Size (US$ Mn) Analysis by Application, 2012-2016

9.8.1. Translational Laboratories

9.8.2. Biopharmaceutical Companies

9.8.3. Academic Institutes

9.9. Market Size (US$ Mn) Forecast, by Application, 2017-2027

9.9.1. Translational Laboratories

9.9.2. Biopharmaceutical Companies

9.9.3. Academic Institutes

9.10. Market Attractiveness Analysis

9.10.1. By Component Type

9.10.2. By Imaging Technique

9.10.3. Application

9.10.4. End User

9.11. Key Representative Market Presence (Intensity Map)

10. Middle East and Africa Multiplex Biomarker Imaging Market Analysis 2012–2016 and Forecast 2017–2027

10.1. Introduction

10.2. Regional Market Dynamics

10.2.1. Drivers

10.2.2. Restraints

10.2.3. Trends

10.3. Historical Market Size (US$ Mn) Analysis By Country, 2012-2016

10.3.1. GCC Countries

10.3.2. South Africa

10.3.3. Rest of MEA

10.4. Market Size (US$ Mn) Forecast By Country, 2017- 2027

10.4.1. GCC Countries

10.4.2. South Africa

10.4.3. Rest of MEA

10.5.Historical Market Size (US$ Mn) and Volume Analysis By Component Type, 2012-2016

10.5.1. Instruments

10.5.1.1. Quantitative Pathology Imaging System

10.5.1.2. Immunofluorescence Slide Scanner

10.5.1.3. Multispectral Imaging Systems

10.5.1.4. Toponome imaging System

10.5.2. Software

10.5.3. Services

10.5.3.1. Installation & Integration Services

10.5.3.2. Maintenance Service

10.6.Market Size (US$ Mn) and Volume Forecast By Component Type, 2017-2027

10.6.1. Instruments

10.6.1.1. Quantitative Pathology Imaging System

10.6.1.2. Immunofluorescence Slide Scanner

10.6.1.3. Multispectral Imaging Systems

10.6.1.4. Toponome imaging System

10.6.2. Software

10.6.3. Services

10.6.3.1. Installation & Integration Services

10.6.3.2. Maintenance Service

10.7.Historical Market Size (US$ Mn) Analysis by Imaging Technique, 2012-2016

10.7.1. Immunohistochemistry (IHC) Assay

10.7.2. Fluorescent In Situ Hybridization (FISH) Assay

10.7.3. Tissue Microarray (TMA) Assay

10.8.Market Size (US$ Mn) Forecast, by Imaging Technique, 2017-2027

10.8.1. Immunohistochemistry (IHC) Assay

10.8.2. Fluorescent In Situ Hybridization (FISH) Assay

10.8.3. Tissue Microarray (TMA) Assay

10.9.Historical Market Size (US$ Mn) Analysis by Application, 2012-2016

10.9.1. Research

10.9.2. Clinical Diagnostics

10.10. Market Size (US$ Mn) Forecast, by Application, 2017-2027

10.10.1. Research

10.10.2. Clinical Diagnostics

10.11. Historical Market Size (US$ Mn) Analysis by Application, 2012-2016

10.11.1. Translational Laboratories

10.11.2. Biopharmaceutical Companies

10.11.3. Academic Institutes

10.12. Market Size (US$ Mn) Forecast, by Application, 2017-2027

10.12.1. Translational Laboratories

10.12.2. Biopharmaceutical Companies

10.12.3. Academic Institutes

10.13. Drivers and Restraints: Impact Analysis

10.14. Market Attractiveness Analysis

10.14.1. By Country

10.14.2. By Component Type

10.14.3. By Imaging Technique

10.14.4. Application

10.14.5. End User

10.15. Key Representative Market Presence (Intensity Map)

11. Forecast Factors: Relevance and Impact

12. Forecast Assumptions

13. Competition Landscape

13.1. Competition Dashboard

13.2. Company Share Analysis

13.3. Company Profiles (Details – Overview, Financials, Strategy, Recent Developments and SWOT Analysis)

13.3.1. Perkin Elmer, Inc.

13.3.2. Bio-rad Laboratories Inc.

13.3.3. Thermo Fisher Scientific, Inc.

13.3.4. Abcam plc.

13.3.5. Merck KGaA

13.3.6. Illumina Inc.

13.3.7. Leica Biosystems Nussloch GmbH

13.3.8. Ventana Medical Systems, Inc.

13.3.9. Aushon BioSystems Ltd.

13.3.10. MicroConstants, Inc.

13.3.11. ToposNomos Ltd.

14. Global Multiplex Biomarker Imaging Market Analysis 2012–2016 and Forecast 2017–2027, By Region

14.1. Introduction / Key Findings

14.2. Historical Market Size (US$ Mn) Analysis By Region, 2012-2016

14.2.1. North America

14.2.2. Latin America

14.2.3. Western Europe

14.2.4. Eastern Europe

14.2.5. Asia Pacific Excluding Japan

14.2.6. Japan

14.2.7. Middle East and Africa

14.3. Market Size (US$ Mn) Forecast By Region, 2017-2027

14.3.1. North America

14.3.2. Latin America

14.3.3. Western Europe

14.3.4. Eastern Europe

14.3.5. Asia Pacific Excluding Japan

14.3.6. Japan

14.3.7. Middle East and Africa

14.4. Market Attractiveness Analysis By Region

15. Global Multiplex Biomarker Imaging Market Analysis 2012–2016 and Forecast 2017–2027, By Component Type

15.1. Introduction

15.2. Historical Market Size (US$ Mn) and Volume Analysis By Component Type, 2012-2016

15.2.1. Instruments

15.2.1.1. Quantitative Pathology Imaging System

15.2.1.2. Immunofluorescence Slide Scanner

15.2.1.3. Multispectral Imaging Systems

15.2.1.4. Toponome imaging System

15.2.2. Software

15.2.3. Services

15.2.3.1. Installation & Integration Services

15.2.4. Maintenance Service

15.3. Market Size (US$ Mn) and Volume Forecast By Component Type,2017-2027

15.3.1. Instruments

15.3.1.1. Quantitative Pathology Imaging System

15.3.1.2. Immunofluorescence Slide Scanner

15.3.1.3. Multispectral Imaging Systems

15.3.1.4. Toponome imaging System

15.3.2. Software

15.3.3. Services

15.3.3.1. Installation & Integration Services

15.3.4. Maintenance Service

15.4. Market Attractiveness Analysis by Component Type

16. Global Multiplex Biomarker Imaging Market Analysis 2012–2016 and Forecast 2017–2027, By Imaging Technique

16.1. Introduction

16.2. Historical Market Size (US$ Mn) Analysis, by Imaging Technique, 2012-2016

16.2.1. Immunohistochemistry (IHC) Assay

16.2.2. Fluorescent In Situ Hybridization (FISH) Assay

16.2.3. Tissue Microarray (TMA) Assay

16.3. Market Size (US$ Mn) Forecast, by Imaging Technique, 2017-2027

16.3.1. Immunohistochemistry (IHC) Assay

16.3.2. Fluorescent In Situ Hybridization (FISH) Assay

16.3.3. Tissue Microarray (TMA) Assay

16.4. Market Attractiveness Analysis by Imaging Technique 

17. Global Multiplex Biomarker Imaging Market Analysis 2012–2016 and Forecast 2017–2027, By Application

17.1. Introduction

17.2. Historical Market Size (US$ Mn) Analysis, by Application, 2012-2016

17.2.1. Research

17.2.2. Clinical Diagnostics

17.3. Market Size (US$ Mn) Forecast, by Application, 2017-2027

17.3.1. Research

17.3.2. Clinical Diagnostics

17.4. Market Attractiveness Analysis by Application

18. Global Multiplex Biomarker Imaging Market Analysis 2012–2016 and Forecast 2017–2027, By End User

18.1. Introduction

18.2. Historical Market Size (US$ Mn) Analysis, by End User, 2012-2016

18.2.1. Translational Laboratories

18.2.2. Biopharmaceutical Companies

18.2.3. Academic Institutes

18.3. Market Size (US$ Mn) Forecast, by End User, 2017-2027

18.3.1. Translational Laboratories

18.3.2. Biopharmaceutical Companies

18.3.3. Academic Institutes

18.4. Market Attractiveness Analysis by End User

19. Global Market Analysis 2012–2016 and Forecast 2017–2027

19.1. Market Size and Y-o-Y Growth

19.2. Absolute $ Opportunity

20. Assumptions and Acronyms Used

21. Research Methodology

Multiplex Biomarker Imaging Market Reports - List of Tables

Table 01: CPT Codes for Digital Pathology

Table 02: DPA Regulatory FDA 510(k) List

Table 03: DPA Regulatory FDA 510(k) List

Table 04: North America Multiplex Biomarker Imaging Market Value (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Component Type

Table 05: North America Multiplex Biomarker Imaging Market Volume Analysis 2012–2016 and Forecast 2017–2027, By Component Type 

Table 06: North America Multiplex Biomarker Imaging Market Value (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Imaging Technique

Table 07: North America Multiplex Biomarker Imaging Market Value (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Application

Table 08: North America Multiplex Biomarker Imaging Market Value (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By End User

Table 09: North America Multiplex Biomarker Imaging Market Value (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Country

Table 10: North America Multiplex Biomarker Imaging Participants Presence (Intensity Mapping)

Table 11: Latin America Multiplex Biomarker Imaging Market Value (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Component Type

Table 12: Latin America Multiplex Biomarker Imaging Market Volume Analysis-2012–2016 and Forecast 2017–2027, By Component Type 

Table 13: Latin America Multiplex Biomarker Imaging Market Value (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Imaging Technique

Table 14: Latin America Multiplex Biomarker Imaging Market Value (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Application

Table 15: Latin America Multiplex Biomarker Imaging Market Value (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By End User

Table 16: Latin America Multiplex Biomarker Imaging Market Value (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Country

Table 17: Latin America Multiplex Biomarker Imaging Participants Presence (Intensity Mapping)

Table 18: Western Europe Multiplex Biomarker Imaging Market Value (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Component Type

Table 19: Western Europe Multiplex Biomarker Imaging Market Volume Analysis-2012–2016 and Forecast 2017–2027, By Component Type 

Table 20: Western Europe Multiplex Biomarker Imaging Market Value (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Imaging Technique

Table 21: Western Europe Multiplex Biomarker Imaging Market Value (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Application

Table 22: Western Europe Multiplex Biomarker Imaging Market Value (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By End User

Table 23: Western Europe  Multiplex Biomarker Imaging Market Value (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Country

Table 24: Western Europe Multiplex Biomarker Imaging Participants Presence (Intensity Mapping)

Table 25: Eastern Europe Multiplex Biomarker Imaging Market Value (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Component Type

Table 26: Eastern Europe Multiplex Biomarker Imaging Market Volume Analysis-2012–2016 and Forecast 2017–2027, By Component Type 

Table 27 : Eastern Europe Multiplex Biomarker Imaging Market Value (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Imaging Technique

Table 28: Eastern Europe Multiplex Biomarker Imaging Market Value (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Application

Table 29: Eastern Europe Multiplex Biomarker Imaging Market Value (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By End User

Table 30: Eastern Europe  Multiplex Biomarker Imaging Market Value (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Country

Table 31: Eastern Europe Multiplex Biomarker Imaging Participants Presence (Intensity Mapping)

Table 32: APEJ Multiplex Biomarker Imaging Market Value (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Component Type

Table 33: APEJ Multiplex Biomarker Imaging Market Volume Analysis-2012–2016 and Forecast 2017–2027, By Component Type 

Table 34: APEJ Multiplex Biomarker Imaging Market Value (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Imaging Technique

Table 35: APEJ Multiplex Biomarker Imaging Market Value (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Application

Table 36: APEJ Multiplex Biomarker Imaging Market Value (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By End User

Table 37: APEJ  Multiplex Biomarker Imaging Market Value (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Country

Table 38: APEJ Multiplex Biomarker Imaging Participants Presence (Intensity Mapping)

Table 39: Japan Multiplex Biomarker Imaging Market Value (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Component Type

Table 40: Japan Multiplex Biomarker Imaging Market Volume Analysis-2012–2016 and Forecast 2017–2027, By Component Type 

Table 41: Japan Multiplex Biomarker Imaging Market Value (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Imaging Technique

Table 42: Japan Multiplex Biomarker Imaging Market Value (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Application

Table 43: Japan Multiplex Biomarker Imaging Market Value (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By End User

Table 44: Japan Multiplex Biomarker Imaging Participants Presence (Intensity Mapping)

Table 45: MEA Multiplex Biomarker Imaging Market Value (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Component Type

Table 46: MEA Multiplex Biomarker Imaging Market Volume Analysis-2012–2016 and Forecast 2017–2027, By Component Type 

Table 47: MEA Multiplex Biomarker Imaging Market Value (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Imaging Technique

Table 48: MEA Multiplex Biomarker Imaging Market Value (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Application

Table 49: MEA Multiplex Biomarker Imaging Market Value (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By End User

Table 50: MEA  Multiplex Biomarker Imaging Market Value (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Country

Table 51: MEA Multiplex Biomarker Imaging Participants Presence (Intensity Mapping)

Table 52:  Global Multiplex Biomarker Imaging Market Value (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Region

Table 53: Global Multiplex Biomarker Imaging Market Value (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Component Type

Table 54: Global Multiplex Biomarker Imaging Market Volume Analysis-2012–2016 and Forecast 2017–2027, By Component Type 

Table 55: Global Multiplex Biomarker Imaging Market Value (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Imaging Technique

Table 56: Global Multiplex Biomarker Imaging Market Value (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Application

Table 57: Global Multiplex Biomarker Imaging Market Value (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By End User

Multiplex Biomarker Imaging Market Reports - List of Figures

Figure 01: U.S FDA Regulatory Approval for Medical Devices

Figure 02: Europe Regulatory Approval for Medical Devices

Figure 03: Japan Regulatory Approval for Medical Devices

Figure 04: North America Multiplex Biomarker Imaging Market Value Share By Component Type (2017)

Figure 06: North America Multiplex Biomarker Imaging Market Value Share By Application (2017)

Figure 05: North America Multiplex Biomarker Imaging Market Value Share By Imaging Technique (2017)

Figure 07: North America Multiplex Biomarker Imaging Market Value Share By End User (2017)

Figure 08: North America Multiplex Biomarker Imaging Market Value Share By Country (2017)

Figure 09: North America Multiplex Biomarker Imaging Historical Market Analysis 2012 - 2016

Figure 10: North America Multiplex Biomarker Imaging Market Forecast, 2017 - 2027

Figure 11: U.S. Multiplex Biomarker Imaging Historical Market Analysis 2012 - 2016

Figure 12: U.S. Multiplex Biomarker Imaging Market Forecast, 2017 - 2027

Figure 13: Canada Multiplex Biomarker Imaging Historical Market Analysis 2012 - 2016

Figure 14: Canada Multiplex Biomarker Imaging Market Forecast, 2017 - 2027

Figure 15: North America Multiplex Biomarker Imaging Market Attractive Analysis By Component Type, 2017-2027

Figure 16: North America Multiplex Biomarker Imaging Market Attractive Analysis By Imaging Technique, 2017-2027

Figure 17: North America Multiplex Biomarker Imaging Market Attractive Analysis By Application, 2017-2027

Figure 18: North America Multiplex Biomarker Imaging Market Attractive Analysis By End User, 2017-2027

Figure 19: North America Multiplex Biomarker Imaging Market Attractive Analysis By Country, 2017-2027

Figure 20: North America - Drivers & Restrains Impact Analysis

Figure 21: Latin America Multiplex Biomarker Imaging Market Value Share By Component Type (2017)

Figure 23: Latin America Multiplex Biomarker Imaging Market Value Share By Application (2017)

Figure 22: Latin America Multiplex Biomarker Imaging Market Value Share By Imaging Technique (2017)

Figure 24: Latin America Multiplex Biomarker Imaging Market Value Share By End User (2017)

Figure 25: Latin America Multiplex Biomarker Imaging Market Value Share By Country (2017)

Figure 26: Latin America Multiplex Biomarker Imaging Historical Market Analysis 2012 - 2016

Figure 27: Latin America Multiplex Biomarker Imaging Market Forecast, 2017 - 2027

Figure 28: Brazil  Multiplex Biomarker Imaging Historical Market Analysis 2012 - 2016

Figure 29: Brazil Multiplex Biomarker Imaging Market Forecast, 2017 - 2027

Figure 30: Mexico Multiplex Biomarker Imaging Historical Market Analysis 2012 - 2016

Figure 31: Mexico Multiplex Biomarker Imaging Market Forecast, 2017 - 2027

Figure 32: Argentina Multiplex Biomarker Imaging Historical Market Analysis 2012 - 2016

Figure 33: Argentina Multiplex Biomarker Imaging Market Forecast, 2017 - 2027

Figure 34: Rest of Latin America Multiplex Biomarker Imaging Historical Market Analysis 2012 - 2016

Figure 35: Rest of Latin America Multiplex Biomarker Imaging Market Forecast, 2012 - 2016

Figure 36: Latin America Multiplex Biomarker Imaging Market Attractive Analysis By Component Type, 2017-2027

Figure 37: Latin America Multiplex Biomarker Imaging Market Attractive Analysis By Imaging Technique, 2017-2027

Figure 38: Latin America Multiplex Biomarker Imaging Market Attractive Analysis By Application, 2017-2027

Figure 39: Latin America Multiplex Biomarker Imaging Market Attractive Analysis By End User, 2017-2027

Figure 40: Latin America Multiplex Biomarker Imaging Market Attractive Analysis By Country, 2017-2027

Figure 41: Latin America - Drivers & Restraint Impact Analysis

Figure 42: Western Europe Multiplex Biomarker Imaging Market Value Share By Component Type (2017)

Figure 44: Western Europe Multiplex Biomarker Imaging Market Value Share By Application (2017)

Figure 43: Western Europe Multiplex Biomarker Imaging Market Value Share By Imaging Technique (2017)

Figure 45: Western Europe Multiplex Biomarker Imaging Market Value Share By End User (2017)

Figure 46: Western Europe Multiplex Biomarker Imaging Market Value Share By Country (2017)

Figure 47: Western Europe  Multiplex Biomarker Imaging Historical Market Analysis 2012 - 2016

Figure 48: Western Europe  Multiplex Biomarker Imaging Market Forecast, 2017 - 2027

Figure 49: U.K. Multiplex Biomarker Imaging Historical Market Analysis 2012 - 2016

Figure 50: U.K. Multiplex Biomarker Imaging Market Forecast, 2017 - 2027

Figure 51: Germany Multiplex Biomarker Imaging Historical Market Analysis 2012 - 2016

Figure 52: Germany Multiplex Biomarker Imaging Market Forecast, 2017 - 2027

Figure 53: France Multiplex Biomarker Imaging Historical Market Analysis 2012 - 2016

Figure 54: France Multiplex Biomarker Imaging Market Forecast, 2017 - 2027

Figure 55: Italy Multiplex Biomarker Imaging Historical Market Analysis 2012 - 2016

Figure 56: Italy Multiplex Biomarker Imaging Market Forecast, 2017 - 2027

Figure 57: Spain Multiplex Biomarker Imaging Historical Market Analysis 2012 - 2016

Figure 58: Spain Multiplex Biomarker Imaging Market Forecast, 2017 - 2027

Figure 59: Nordics Multiplex Biomarker Imaging Historical Market Analysis 2012 - 2016

Figure 60: Nordics Multiplex Biomarker Imaging Market Forecast, 2017 - 2027

Figure 61: Benelux Multiplex Biomarker Imaging Historical Market Analysis 2012 - 2016

Figure 62: Benelux Multiplex Biomarker Imaging Market Forecast, 2017 - 2027

Figure 63: Rest of Western Europe  Multiplex Biomarker Imaging Historical Market Analysis 2012 - 2016

Figure 64: Rest of Western Europe  Multiplex Biomarker Imaging Market Forecast, 2017 - 2027

Figure 65: Western Europe Multiplex Biomarker Imaging Market Attractive Analysis By Component Type, 2017-2027

Figure 66: Western Europe Multiplex Biomarker Imaging Market Attractive Analysis By Imaging Technique, 2017-2027

Figure 67: Western Europe Multiplex Biomarker Imaging Market Attractive Analysis By Application, 2017-2027

Figure 68: Western Europe Multiplex Biomarker Imaging Market Attractive Analysis By End User, 2017-2027

Figure 69: Western Europe Multiplex Biomarker Imaging Market Attractive Analysis By Component Type, 2017-2027

Figure 70: Europe - Drivers & Restraint Impact Analysis

Figure 70: Eastern Europe Multiplex Biomarker Imaging Market Value Share By Component Type (2017)

Figure 72: Eastern Europe Multiplex Biomarker Imaging Market Value Share By Application (2017)

Figure 71: Eastern Europe Multiplex Biomarker Imaging Market Value Share By Imaging Technique (2017)

Figure 73: Eastern Europe Multiplex Biomarker Imaging Market Value Share By End User (2017)

Figure 74: Eastern Europe Multiplex Biomarker Imaging Market Value Share By Country (2017)

Figure 75: Eastern Europe  Multiplex Biomarker Imaging Historical Market Analysis 2012 - 2016

Figure 76: Eastern Europe  Multiplex Biomarker Imaging Market Forecast, 2017 - 2027

Figure 77: Russia Multiplex Biomarker Imaging Historical Market Analysis 2012 - 2016

Figure 78: Russia Multiplex Biomarker Imaging Market Forecast, 2017 - 2027

Figure 79: Poland Multiplex Biomarker Imaging Historical Market Analysis 2012 - 2016

Figure 80: Poland Multiplex Biomarker Imaging Market Forecast, 2017 - 2027

Figure 81: Rest of Eastern Europe  Multiplex Biomarker Imaging Historical Market Analysis 2012 - 2016

Figure 82: Rest of Eastern Europe  Multiplex Biomarker Imaging Market Forecast, 2017 - 2027

Figure 83: Eastern Europe Multiplex Biomarker Imaging Market Attractive Analysis By Component Type, 2017-2027

Figure 84: Eastern Europe Multiplex Biomarker Imaging Market Attractive Analysis By Imaging Technique, 2017-2027

Figure 85: Eastern Europe Multiplex Biomarker Imaging Market Attractive Analysis By Application, 2017-2027

Figure 86: Eastern Europe Multiplex Biomarker Imaging Market Attractive Analysis By End User, 2017-2027

Figure 87: Eastern Europe Multiplex Biomarker Imaging Market Attractive Analysis By Component Type, 2017-2027

Figure 88: APEJ Multiplex Biomarker Imaging Market Value Share By Component Type (2017)

Figure 90: APEJ Multiplex Biomarker Imaging Market Value Share By Application (2017)

Figure 89: APEJ Multiplex Biomarker Imaging Market Value Share By Imaging Technique (2017)

Figure 91: APEJ Multiplex Biomarker Imaging Market Value Share By End User (2017)

Figure 92: APEJ Multiplex Biomarker Imaging Market Value Share By Country (2017)

Figure 93: APEJ  Multiplex Biomarker Imaging Historical Market Analysis 2012 - 2016

Figure 94: APEJ  Multiplex Biomarker Imaging Market Forecast, 2017 - 2027

Figure 95:China Multiplex Biomarker Imaging Historical Market Analysis 2012 - 2016

Figure 96: China Multiplex Biomarker Imaging Market Forecast, 2017 - 2027

Figure 97: India Multiplex Biomarker Imaging Historical Market Analysis 2012 - 2016

Figure 98: India Multiplex Biomarker Imaging Market Forecast, 2017 - 2027

Figure 99: Australia and NZ Multiplex Biomarker Imaging Historical Market Analysis 2012 - 2016

Figure 100: Australia and NZ Multiplex Biomarker Imaging Market Forecast, 2017 - 2027

Figure 101: ASEAN Multiplex Biomarker Imaging Historical Market Analysis 2012 - 2016

Figure 102: ASEAN Multiplex Biomarker Imaging Market Forecast, 2017 - 2027

Figure 103: Rest of APEJ  Multiplex Biomarker Imaging Historical Market Analysis 2012 - 2016

Figure 104: Rest of APEJ  Multiplex Biomarker Imaging Market Forecast, 2017 - 2027

Figure 105: APEJ Multiplex Biomarker Imaging Market Attractive Analysis By Component Type, 2017-2027

Figure 106: APEJ Multiplex Biomarker Imaging Market Attractive Analysis By Imaging Technique, 2017-2027

Figure 107: APEJ Multiplex Biomarker Imaging Market Attractive Analysis By Application, 2017-2027

Figure 108: APEJ Multiplex Biomarker Imaging Market Attractive Analysis By End User, 2017-2027

Figure 109: APEJ Multiplex Biomarker Imaging Market Attractive Analysis By Component Type, 2017-2027

Figure 110: APAC - Drivers & Restraint Impact Analysis

Figure 111: Japan Multiplex Biomarker Imaging Market Value Share By Component Type (2017)

Figure 113: Japan Multiplex Biomarker Imaging Market Value Share By Application (2017)

Figure 112: Japan Multiplex Biomarker Imaging Market Value Share By Imaging Technique (2017)

Figure 114: Japan Multiplex Biomarker Imaging Market Value Share By End User (2017)

Figure 115: Japan  Multiplex Biomarker Imaging Historical Market Analysis 2012 - 2016

Figure 116: Japan  Multiplex Biomarker Imaging Market Forecast, 2017 - 2027

Figure 117: Japan Multiplex Biomarker Imaging Market Attractive Analysis By Component Type, 2017-2027

Figure 118: Japan Multiplex Biomarker Imaging Market Attractive Analysis By Imaging Technique, 2017-2027

Figure 119: Japan Multiplex Biomarker Imaging Market Attractive Analysis By Application, 2017-2027

Figure 120: Japan Multiplex Biomarker Imaging Market Attractive Analysis By End User, 2017-2027

Figure 121: MEA Multiplex Biomarker Imaging Market Value Share By Component Type (2017)

Figure 123: MEA Multiplex Biomarker Imaging Market Value Share By Application (2017)

Figure 122: MEA Multiplex Biomarker Imaging Market Value Share By Imaging Technique (2017)

Figure 124: MEA Multiplex Biomarker Imaging Market Value Share By End User (2017)

Figure 125: MEA Multiplex Biomarker Imaging Market Value Share By Country (2017)

Figure 126: MEA  Multiplex Biomarker Imaging Historical Market Analysis 2012 - 2016

Figure 127: MEA  Multiplex Biomarker Imaging Market Forecast, 2017 - 2027

Figure 128: South Africa Multiplex Biomarker Imaging Historical Market Analysis 2012 - 2016

Figure 129: South Africa Multiplex Biomarker Imaging Market Forecast, 2017 - 2027

Figure 130: GCC Countries Multiplex Biomarker Imaging Historical Market Analysis 2012 - 2016

Figure 131: GCC Countries Multiplex Biomarker Imaging Market Forecast, 2017 - 2027

Figure 132: Rest of MEA  Multiplex Biomarker Imaging Historical Market Analysis 2012 - 2016

Figure 133: Rest of MEA  Multiplex Biomarker Imaging Market Forecast, 2017 - 2027

Figure 134: MEA Multiplex Biomarker Imaging Market Attractive Analysis By Component Type, 2017-2027

Figure 135: MEA Multiplex Biomarker Imaging Market Attractive Analysis By Imaging Technique, 2017-2027

Figure 136: MEA Multiplex Biomarker Imaging Market Attractive Analysis By Application, 2017-2027

Figure 137: MEA Multiplex Biomarker Imaging Market Attractive Analysis By End User, 2017-2027

Figure 138: MEA Multiplex Biomarker Imaging Market Attractive Analysis By Component Type, 2017-2027

Figure 139: MEA Drivers & Restraint Impact Analysis

Figure 140: Global Multiplex Biomarker Imaging Market Share Analysis

Figure 141: Global Multiplex Biomarker Imaging Market Attractive Analysis By Region, 2017-2027

Figure 142: Global Multiplex Biomarker Imaging Market Attractive Analysis By Component , 2017-2027

Figure 143: Global Multiplex Biomarker Imaging Market Attractive Analysis By Imaging Techniques, 2017-2027

Figure 144: Global Multiplex Biomarker Imaging Market Attractive Analysis By Application, 2017-2027

Figure 145: Global Multiplex Biomarker Imaging Market Attractive Analysis By End User, 2017-2027

Figure 146: Global Multiplex Biomarker Imaging Historical Market Analysis 2012 - 2016

Figure 147: Global Multiplex Biomarker Imaging Market Forecast, 2017 - 2027

Figure 148: Global Multiplex Biomarker Imaging Market Absolute $ Opportunity, 2012 - 2016

Figure 149: Global Multiplex Biomarker Imaging Market Absolute $ Opportunity, 2017 - 2027